The impact of polypharmacy on adherence to pharmacotherapy for coronary heart disease with comorbid conditions: insights from the EUROASPIRE V observational study in Ukraine

The impact of polypharmacy on adherence to pharmacotherapy for coronary heart disease with comorbid conditions: insights from the EUROASPIRE V observational study in Ukraine

It is known that coronary heart disease (CHD) is the leading cause of mortality among non-communicable diseases worldwide, including in Ukraine. The results of the EUROASPIRE V observational study showed an insufficient level of adherence to treatment in patients with CHD and comorbid conditions acr...

Full description

Saved in:
Bibliographic Details
Main Authors: M. M. Dolzhenko, N. A. Bilousova, L. I. Yakovenko, V. A. Nesukai, N. A. Kozhuharyova
Format: Article
Language:English
Published: Zaporizhzhia State Medical and Pharmaceutical University 2025-06-01
Series:Сучасні медичні технології
Subjects:
polypharmacy
drug interactions
coronary heart disease
chd pharmacotherapy
pharmaceutical care
drug compatibility
Online Access:https://medtech.mphu.edu.ua/article/view/322403/322361
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://medtech.mphu.edu.ua/article/view/322403/322361

Similar Items